Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration

NCT00793702 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Statens Serum Institut